Dashboard / Index chart

Nifty Pharma

Daily OHLC history, trend, risk, returns, and index valuation from NSE archives.

25,565.9

-0.2% latest completed session

1M return

-5.4%

3M return

-0.7%

6M return

+13.2%

1Y return

+13.5%

Combined leadership read · through 21 Oct 2026

Mixed evidence

Price structure and relative performance versus Nifty 50 are not giving the same directional confirmation.

Price

Testing support

vs Nifty 50

Weakening

Price Trend

744 daily sessions · latest 21 Oct 2026

3M 6M 1Y 3Y

Index chartsNifty 50 Next 50 Nifty 100 Nifty 500 Bank Nifty Midcap 150 Smallcap 250 Nifty IT

All indices

Nifty Pharma daily price

744 observations

21 Oct 2026O 25,672.2H 25,797.55L 25,279.15C 25,565.9-0.19%

Nifty Pharma25.6k

SMA 50

SMA 200

Trend & Risk Context

Price regime uses daily closes; volatility and drawdown use the selected 3Y window.

Trend regime

Mixed

From 52W high

-6.2%

52W position

72.3%

Annualised vol

15.1%

3Y max drawdown

−16.7%

50 / 200 DMA

26,484 / 24,359

Breakout, Support & Resistance

Prior-session Donchian levels with ATR-based price confirmation.

Testing support

20D support

25,565

20D resistance

27,255

Gap above support

0.0%

Gap to resistance

6.6% below

ATR 14

428

20D channel position

0.0%

50-session channel: 25,565 support and 27,255 resistance. Confirmation is price-only because NSE index archives do not provide dependable index volume. Completed-session analysis through 21 Oct 2026; levels are context, not forecasts or trade calls.

Relative Strength vs Nifty 50

Close-to-close ratio rebased to 100 at the start of the selected window.

Weakening

1M relative return

-2.9%

3M relative return

+4.4%

20-session momentum

-2.9%

From prior 63D high

-5.5%

Nifty Pharma relative-strength ratio

744 observations

21 Oct 2026Value 144.92+0.15%

Nifty Pharma / Nifty 50144.92

SMA 50

A rising ratio means Nifty Pharma is outperforming Nifty 50; a falling ratio means it is lagging. Relative strength is confirmation, not a standalone buy or sell signal.

Index Valuation History

Nifty Pharma valuation versus its own trailing history.

NSE archive source

Price to earnings · latest 39.62x

Higher than 73% of one-year observations

P/E daily history

743 observations

21 Oct 2026Value 39.62-0.65%

P/E39.62

Historical percentile is context, not a buy or sell threshold. Read P/E, P/B, and yield together with earnings, rates, and market regime.

Open Scanner

Find stocks aligned with this market move

Sector Heatmap

Compare U-Score quality by sector

Back to Dashboard

Return to Market Pulse